<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Peripheral Blood-Derived Virus-Specific Memory Stem T Cells Mature to Functional Effector Memory Subsets with Self-Renewal Potency</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Michael</forename><surname>Schmueck-Henneresse</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute for Medical Immunology</orgName>
								<orgName type="institution">Charite ´University Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Nephrology and Internal Intensive Care</orgName>
								<orgName type="laboratory">Renal and Transplant Research Unit</orgName>
								<orgName type="institution">Charite ´University Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies</orgName>
								<orgName type="institution">Charite ´Univer-sity Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Radwa</forename><surname>Sharaf</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute for Medical Immunology</orgName>
								<orgName type="institution">Charite ´University Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Katrin</forename><surname>Vogt</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute for Medical Immunology</orgName>
								<orgName type="institution">Charite ´University Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Benjamin</forename><forename type="middle">J D</forename><surname>Weist</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Nephrology and Internal Intensive Care</orgName>
								<orgName type="laboratory">Renal and Transplant Research Unit</orgName>
								<orgName type="institution">Charite ´University Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sybille</forename><surname>Landwehr-Kenzel</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies</orgName>
								<orgName type="institution">Charite ´Univer-sity Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">School for Regenerative Therapies</orgName>
								<orgName type="institution">Charite ´University Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin-Brandenburg, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department for Pediatric Pulmonology and Immunology</orgName>
								<orgName type="institution">Charite ´Univer-sity Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Henrike</forename><surname>Fuehrer</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Nephrology and Internal Intensive Care</orgName>
								<orgName type="laboratory">Renal and Transplant Research Unit</orgName>
								<orgName type="institution">Charite ´University Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies</orgName>
								<orgName type="institution">Charite ´Univer-sity Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Anke</forename><surname>Jurisch</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute for Medical Immunology</orgName>
								<orgName type="institution">Charite ´University Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies</orgName>
								<orgName type="institution">Charite ´Univer-sity Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nina</forename><surname>Babel</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies</orgName>
								<orgName type="institution">Charite ´Univer-sity Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="institution" key="instit1">Marien Hospital Herne</orgName>
								<orgName type="institution" key="instit2">Ruhr University Bochum</orgName>
								<address>
									<postCode>D-44625</postCode>
									<settlement>Herne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Cliona</forename><forename type="middle">M</forename><surname>Rooney</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Center for Cell and Gene Ther-apy</orgName>
								<orgName type="institution">Baylor College of Medicine</orgName>
								<address>
									<postCode>77030</postCode>
									<settlement>Houston</settlement>
									<region>TX</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Petra</forename><surname>Reinke</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Nephrology and Internal Intensive Care</orgName>
								<orgName type="laboratory">Renal and Transplant Research Unit</orgName>
								<orgName type="institution">Charite ´University Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies</orgName>
								<orgName type="institution">Charite ´Univer-sity Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hans-Dieter</forename><surname>Volk</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute for Medical Immunology</orgName>
								<orgName type="institution">Charite ´University Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Berlin-Brandenburg Center for Regenerative Therapies</orgName>
								<orgName type="institution">Charite ´Univer-sity Medicine Berlin</orgName>
								<address>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">The American Association of Immunologists, Inc</orgName>
								<address>
									<addrLine>Suite 650</addrLine>
									<postCode>1451, 20852</postCode>
									<settlement>Rockville Pike, Rockville</settlement>
									<region>MD</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<orgName type="department">Institute for Medical Immunology and Berlin-Brandenburg Center for Regenerative Therapies</orgName>
								<orgName type="institution">Charite ´University Medicine Berlin</orgName>
								<address>
									<addrLine>Augustenburger Platz 1</addrLine>
									<postCode>D-13353</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Peripheral Blood-Derived Virus-Specific Memory Stem T Cells Mature to Functional Effector Memory Subsets with Self-Renewal Potency</title>
					</analytic>
					<monogr>
						<idno type="ISSN">0022-1767</idno>
					</monogr>
					<idno type="MD5">DF6B1608CBD459E23E34939020B003C5</idno>
					<idno type="DOI">10.4049/jimmunol.1402090</idno>
					<note type="submission">Received for publication August 13, 2014. Accepted for publication March 27, 2015.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:27+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Memory T cells expressing stem cell-like properties have been described recently.</s><s>The capacity of self-renewal and differentiation into various memory/effector subsets make them attractive for adoptive T cell therapy to combat severe virus infections and tumors.</s><s>The very few reports on human memory stem T cells (T SCM ) are restricted to analyses on polyclonal T cells, but extensive data on Ag-specific T SCM are missing.</s><s>This might be due to their very low frequency limiting their enrichment and characterization.</s><s>In this article, we provide functional and phenotypic data on human viral-specific T SCM , defined as CD8 + CD45RA + CCR7 + CD127 + CD95 + .</s><s>Whereas &lt;1% of total T cells express the T SCM phenotype, human CMV-specific T SCM can be detected at frequencies similar to those seen in other subsets, resulting in ∼1/10,000 human CMV-specific T SCM.</s><s>A new virus-specific expansion protocol of sort-purified T SCM reveals both upregulation of various T cell subset markers and preservation of their stem cell phenotype in a significant proportion, indicating both self-renewal and differentiation potency of virus-specific T cells sharing their TCR repertoire.</s><s>Furthermore, we describe a simplified culture protocol that allows fast expansion of virus-specific T SCM starting from a mixed naive T/T SCM pool of PBLs.</s><s>Due to the clinical-grade compatibility, this might be the basis for novel cell therapeutic options in life-threatening courses of viral and tumor disease.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>ing pathway supports expansion of T CM without loss of CD62L/ CCR7 <ref type="bibr" target="#b14">(11)</ref>.</s><s>The introduction of T SCM that resemble an earlier stage of memory T cell differentiation opens new opportunities for transfer of stem cell-like cells for improved long-term efficacy.</s><s>T SCM are capable of reconstituting the full diversity of memory and effector T lymphocytes on serial transplantation in mice, indicating that these cells are endowed with the stem cell-like attributes of self-renewal capacity and multipotency <ref type="bibr" target="#b16">(13)</ref>.</s><s>These qualities make T SCM a particularly attractive subset to use in adoptive T cell therapies and promise long-term efficacy.</s><s>Although the instructive signals guiding the formation of T SCM have just begun to be investigated, clinical-grade-compliant protocols to facilitate translation of T SCM into clinical studies remain undefined.</s><s>The published data from human studies are restricted to analyses on total polyclonal T cell populations, and extensive data on Agspecific T SCM are still missing.</s><s>This might be due to the low frequency of those specific T SCM cells making their access limited.</s></p><p><s>Gattinoni et al. <ref type="bibr" target="#b11">(8)</ref> and Cieri et al. <ref type="bibr" target="#b16">(13)</ref> identified human CMV (HCMV)-specific T SCM within the T N compartment and demonstrated that most HCMV-tetramer binding T N of HCMVseropositive donors highly express CD95.</s><s>However, it remains to be elucidated whether these HCMV-tetramer binding CD95 + T N (defined as T SCM ) can exhibit rapid effector T cell functions upon short-term activation, which denotes a hallmark of T cell memory <ref type="bibr" target="#b17">(14)</ref>.</s></p><p><s>In this article, we describe the precise phenotype of T SCM specific to viral Ags.</s><s>Further, we demonstrate that the generation of virus-specific T SCM from the whole-blood naive (CD45RA + CCR7 + ) T cell pool is feasible and making the procedure more feasible for clinical-grade application.</s><s>We found that T SCM , defined by the expression of CD45RA + , CCR7 + , CD127 + , and CD95 + , produce effector cytokines after short-term ex vivo virusantigenic stimulation.</s><s>In our hands, specifically expanded T SCM differentiated into distinct memory/effector subsets while partially preserving their T SCM phenotype.</s><s>This indicates self-renewal capacities upon antigenic stimulation and supports our hypothesis that T SCM should be considered a phenotypic and functional distinct population.</s><s>By further improvement of the virus-specific expansion procedure, we finally developed a protocol that will enable us to rapidly translate the generation of virus-specific T SCM from peripherally collected mixed CD45RA + CCR7 + naive T/T SCM blood lymphocytes to clinical applications.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture</head><p><s>All cell cultures and assays were performed using complete media (RPMI 1640 supplemented with 2 mM L-glutamine, penicillin [100 IU/ml], and streptomycin, all from Biochrom), containing 10% FBS (PAA), in humidified incubators at 37˚C and 5% CO 2 .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Blood samples</head><p><s>For all experiments, blood samples were collected from healthy volunteers.</s><s>PBMCs were isolated by lymphopreparation density gradient centrifugation (PAA).</s><s>The Charite ´ethics committee (Institutional Review Board) approved the study protocol, and all blood donors provided written, informed consent.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>T cell isolation and sorting</head><p><s>PBMCs were enriched for CD3 + T cells with the Pan T cell Isolation Kit II (Miltenyi Biotech) following the manufacturer's instructions.</s><s>Cells were labeled with anti-CD3, anti-CD45RO, anti-CD95, anti-CCR7 (all purchased from Biolegend), and anti-CD45RA (Beckman Coulter) fluorescent Abs.</s><s>FACSort was performed for T N , T N -CD95 depleted , T SCM <ref type="bibr" target="#b18">(15)</ref>, and memory CD3 + T cells (T MEM ) on BD FACSAriaII SORP (BD Biosciences) populations.</s><s>Postsorting analysis of purified subsets revealed .98%</s><s>purity.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell stimulation and expansion</head><p><s>Sorted T lymphocytes were activated at a ratio of 1:10 by irradiated (30 Gy) CD3-depleted autologous PBMCs pulsed with HCMV pp65/IE1 overlapping peptide-pool, NLVPMVATV (hereafter referred to as NLVP) single peptide (known to be immunodominant in HLA-A2 + donors) in HLA-A2 or EBV EBNA1/EBNA2/EBNA3c/LMP1/LMP2/BLZF overlapping peptide pool at 1 mg/ml each peptide (all JPT Peptide Technologies).</s><s>Cells were cultured in the presence of recombinant human IL-7 and IL-15 (Cellgenix) at 10 ng/ml each, followed by restimulation at day 7 with freshly isolated peptide-pool pulsed and irradiated CD3-depleted autologous PBMCs at ratio of 1:10.</s><s>Peptide pools consisted of 15-mer peptides overlapped by 11 aa and were reconstituted in DMSO <ref type="bibr" target="#b19">(16)</ref>.</s><s>The medium was changed every 3-4 d during culture.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Allocation of APCs</head><p><s>Expanded T lymphocytes were analyzed for effector functions by their ability to recognize peptide-loaded target cells, which constituted autologous lymphoblastoid B cell lines (LCL) transformed with B95-8 EBV.</s><s>LCL were generated as described previously <ref type="bibr" target="#b20">(17,</ref><ref type="bibr" target="#b21">18)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Flow cytometry, Abs, and intracellular staining</head><p><s>After Ag-specific stimulation, cytokine formation (IFN-g and TNF-a), activation marker expression (CD137), and cytotoxicity (Granzyme B) were determined by intracellular fluorescence staining.</s><s>All Abs were purchased from Biolegend, unless indicated otherwise.</s><s>Peptide-pool loaded LCL (serving as APC) were added to T cells in a dilution ratio of 1:10.</s><s>Unpulsed LCL (DMSO incubated) were used as unstimulated control.</s><s>For effector cytokine detection, cultured T cells were restimulated for 12 h in the presence of 1 mg/ml brefeldin A (Sigma-Aldrich).</s><s>After harvesting, phenotype staining was performed using mAbs for CD3 (UCHT1; eBioscience), CD4 (OKT4), and CD8 (3B5; Invitrogen).</s><s>To define memory subsets, T cells were extracellularly stained for CCR7 (150503; R&amp;D), CD11a (LFA-1 a-chain, HI111), CD18 (LFA-1 b-chain, TS1/18), CD31 (WM59), CD38 (HB-7), CD161 (HP-3G10), CD183 (CXCR3, G025H7), CD184 (CXCR4, 12G5), CD218a (IL-18Ra, H44), CD45RA (2H4LDH11LDB9; Beckman Coulter), CD45RO (UCHL1), CD95 (DX2), and CD127 (hIL-7R-M21; BD Biosciences), and intracellularly stained for Bcl-2 (100).</s><s>To exclude dead cells, we added live/dead-discrimination staining dye (Invitrogen).</s><s>Subsequently, cells were permeabilized with Perm2 solution (BD Biosciences) and stained for IFN-g (4S.B3; eBioscience), TNF-a (MAb11; BD), CD137 (4B4-1; BD), and Granzyme B (GB11; BD Biosciences).</s><s>NLVP-Ag-specific T cells were identified using MHC multimers (MHC Dextramers from Immudex).</s><s>Cells were analyzed on an LSR-II Fortessa flow cytometer and FlowJo Version 9 software (Tree Star).</s><s>Lymphocytes were gated based on the forward scatter (FSC) versus side scatter profile and subsequently gated on FSC (height) versus FSC (area) to exclude doublets.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>TCR next-generation sequencing</head><p><s>CDR3 sequencing was performed on the ImmunoSEQ platform at Adaptive Biotechnologies as previously described by Robins et al. <ref type="bibr" target="#b22">(19)</ref> and Sherwood et al. <ref type="bibr" target="#b23">(20)</ref>.</s><s>Sequences that did not match CDR3 sequences were removed from the analysis.</s><s>For further analysis, the standard algorithm as developed by Adaptive Biotechnologies and previously described by Yousfi Monod et al. <ref type="bibr" target="#b24">(21)</ref> was used.</s><s>Genomic DNA was isolated using QIAamp DNA Mini Kit from Qiagen according to manufacturer's instructions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Quantitative real-time PCR</head><p><s>RNA of HCMV specifically expanded T MEM and T SCM (days 14-42) was extracted using NucleoSpin RNA II Kit (Macherey-Nagel) following manufacturer's instructions.</s><s>Up to 1 mg RNA was used for cDNA synthesis according to the QuantiTect Reverse Transcription Kit (Qiagen) manual.</s><s>hHPRT was used for the normalization of expression levels.</s><s>Quantitative real-time PCR analysis was performed using TaqMan Universal PCR Master Mix and ready-to-use detections system, containing FAM-TAMRA-labeled probes that were purchased from Applied Biosystems (ABI).</s><s>All expression levels were analyzed in duplicate using ABI Prism 7500 Sequence detections system and associated software (all from ABI).</s><s>All expression levels were calculated relative to hHPRT expression levels.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis and calculations</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Functional viral-specific CD95 + T SCM can be identified after short-term ex vivo stimulation Recent studies revealed that most HCMV-multimer binding T N highly express CD95 <ref type="bibr" target="#b11">(8,</ref><ref type="bibr" target="#b16">13)</ref>, described as T SCM .</s><s>To assess whether T SCM can acquire rapid antiviral memory-like effector T cell functionality, we analyzed the HCMV-specific T cell response ex vivo.</s><s>To this end, human PBMCs were stimulated ex vivo with HCMV pp65/IE1 overlapping peptide pools over 12 h.</s><s>According to CCR7 and CD45RA expression, T cells were subdivided into four memory subsets: T EMRA , T CM , T EM , and T N (Fig. <ref type="figure" target="#fig_0">1A-D</ref>) <ref type="bibr" target="#b10">(7)</ref>.</s><s>T SCM can be found within the T N compartment; most importantly, of these, a small subset expresses large amounts of CD95.</s><s>According to the phenotype published by Gattinoni et al. <ref type="bibr" target="#b11">(8)</ref>, we defined T SCM as CD45RO 2 , CD45RA + , CCR7 + , CD127 + , and CD95 + T cells within both the CD4 + and the CD8 + T cell populations (Fig. <ref type="figure" target="#fig_0">1E</ref>).</s></p><p><s>Upon activation, we found a gradual virus-specific cytokine formation capacity in distinct T cell subsets with the lowest in T N , intermediate in T CM , and the highest in T EM /T EMRA (Fig. <ref type="figure" target="#fig_0">1B-D</ref>).</s><s>Intriguingly, a substantial fraction of the CD8 + T SCM , but only very few CD4 + T SCM produced IFN-g and TNF-a after HCMVspecific stimuli, and their frequency tended to correlate with that of the average total CD3 + T cell population (Fig. <ref type="figure" target="#fig_0">1E-K</ref>).</s><s>By contrast, T SCM of HCMV-seronegative donors like other memory T cell subsets failed to respond to HCMV-antigenic stimuli (data not shown).</s><s>Furthermore, ex vivo HCMV NLVP -multimer staining of CD8 + T cells within PBMCs confirmed the intracellular cytokine formation data and revealed similar gradual viral specificity in frequencies within the T cell subsets and, importantly, multimer positivity of CD8 + T SCM (Supplemental Fig. <ref type="figure" target="#fig_0">1A</ref>).</s><s>T N is the most abundant population within CD4 + and CD8 + T cells with negligible capacity to secrete effector cytokines after ex vivo stimulation (Fig. <ref type="figure" target="#fig_0">1B-D</ref>).</s><s>Intriguingly, the absolute number of T SCM responding to HCMV stimuli correlates with that of the few responding T cells within the T N compartment (Fig. <ref type="figure" target="#fig_0">1H, 1K</ref>), indicating that most IFN-g-and TNF-a-producing T cells within the T N compartment are rather Ag-specific T SCM than T N (Fig. <ref type="figure" target="#fig_0">1H,  1K</ref>).</s><s>Further phenotypic analysis of T cell differentiation markers important to define T SCM <ref type="bibr" target="#b11">(8)</ref> revealed that CD4 + and CD8 + T SCM express, compared with T N cells, higher levels of LFA-1 (a-and b-chain), IL18Ra, and CXCR3, similar levels of Bcl-2 and CD161, and lower levels of CXCR4, CD31, and CD38 (Fig. <ref type="figure" target="#fig_0">1L</ref>; mean fluorescence intensity of each marker is presented in Supplemental Fig. <ref type="figure" target="#fig_0">1B</ref>).</s></p><p><s>In summary, T SCM are phenotypically assigned to the memory compartment and acquire a memory-like effector T cell cytokine formation pattern after Ag rechallenge, allowing detection of functional antiviral-specific T SCM by their effector cytokine production after short-term ex vivo stimulation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Viral-specific T SCM proliferate, show effector T cell functionality, differentiate, and self-renew on antigenic stimuli</head><p><s>To investigate whether HCMV-specific T SCM can be isolated and expanded from peripherally collected PBMCs, we performed sequential cell sorting followed by HCMV-specific T cell activation.</s><s>To this end, CD3 + T cells were enriched from freshly isolated PBMCs by magnetic bead sorting.</s><s>Next, T SCM (CD3 + CD45RA + CCR7 + CD95 + ) and T MEM (CD3 + CD45RO + ) subsets were further purified by polychromatic FACS (FACSorting) (Fig. <ref type="figure" target="#fig_1">2A, 2B</ref>) <ref type="bibr" target="#b18">(15)</ref>.</s><s>The average yield of T SCM reached ∼1% from presorted CD3 + T cells (3.3 3 10 5 6 1.5 3 10 5 T SCM per 3 3 10 7 total T cells; Fig. <ref type="figure" target="#fig_1">2C</ref>).</s><s>Next, T SCM and T MEM were stimulated with autologous, lethally irradiated CD3-depleted PBMCs pulsed with HCMV pp65/IE1 peptide pool in the presence of low-dose IL-7 and IL-15 (Fig. <ref type="figure" target="#fig_2">3A</ref>) <ref type="bibr" target="#b16">(13)</ref>.</s></p><p><s>Cell cultures were assessed for specific expansion of T MEMderived [T (TMEM) ] and T SCM -derived [T (TSCM) ] cells.</s><s>Both subsets showed rapid expansion with T (TSCM) resulting in a higher and more robust yield than T (TMEM) (Fig. <ref type="figure" target="#fig_2">3B, 3C</ref>).</s><s>Interestingly, these culture conditions induced predominant proliferation of CD8 + T cells, whereas CD4 + T cell expansion was essentially absent (Fig. <ref type="figure" target="#fig_2">3D</ref>; data not shown for CD4 + T cells).</s><s>The expression of CD95, a hallmark for memory T cells <ref type="bibr" target="#b17">(14)</ref>, was detectable on every subset analyzed at any time point measured during the course of expansion (data not shown).</s><s>We confirmed presence of the T SCM population in all healthy donors measured in this study (mean = 3.14% of naive-like CD3 + T cells, SD 1.21; Fig. <ref type="figure" target="#fig_1">2C</ref>).</s></p><p><s>We next assessed the effector cytokine response of expanded T MEM and T SCM upon HCMV-specific activation.</s><s>Intriguingly, specific HCMV activation induced IFN-g and TNF-a cytokine formation in both expanded CD8 + T MEM and expanded CD8 + T SCM (Fig. <ref type="figure" target="#fig_2">3E, 3F</ref>).</s><s>Consequently, owing to the higher overall fold expansion rate of T (TSCM) compared with T (TMEM) (Fig. <ref type="figure" target="#fig_2">3B</ref>), HCMV-specific T SCM expansion was significantly higher (Fig. <ref type="figure" target="#fig_2">3H, 3J</ref>).</s><s>Furthermore, HCMV specifically expanded CD8 + T MEM and expanded CD8 + T SCM were capable of becoming cytotoxic effectors expressing Granzyme B (Fig. <ref type="figure" target="#fig_2">3G</ref>).</s><s>Similar results were observed when this protocol was used for the expansion of EBVspecific T SCM .</s><s>T (TSCM) expanded with EBV-antigenic stimuli produce effector cytokines and upregulate activation markers after EBV stimulation (Supplemental Fig. <ref type="figure" target="#fig_0">1C</ref>).</s><s>To confirm Ag specificity, we stimulated HCMV specifically expanded T (TSCM) with unrelated antigenic stimuli (EBV Ags).</s><s>As assessed by FACS analysis, activation by non-HCMV Ags did not induce cytokine formation in HCMV specifically expanded T (TSCM) (Supplemental Fig. <ref type="figure" target="#fig_0">1D</ref>).</s></p><p><s>Specific HCMV activation induced effector cytokine formation in both expanded T MEM and T SCM .</s><s>However, it remains unclear whether both subsets show overlapping TCR usage indicating comparable HCMV epitope specificities.</s><s>To this end, we performed TCR repertoire analyses by next generation sequencing to assess the clonal overlap between T MEM and T SCM .</s><s>These two differentially expanded cell products of three different donors (HCMV pp65/IE1 peptide-pool specifically expanded T MEM and T SCM ) were analyzed.</s><s>Intriguingly, comparison of unique nucleotide sequences revealed a high clonal overlap between the two populations within the same donor (0.436-0.721).</s><s>In contrast, comparison of clonal repertoires between different individuals showed almost no overlap (0.001-0.072), confirming the specificity of the findings (Fig. <ref type="figure" target="#fig_2">3K</ref>).</s><s>In conclusion, expanded HCMVspecific T MEM and T SCM share strongly the TCR repertoire usage indicating the majority of those cells is derived from the same mother clones with identical viral epitope specificity.</s></p><p><s>During the first expansion phase, T (TSCM) expression of CD45RA and CCR7 decreased while CD45RO expression was upregulated, a phenotype traditionally associated with memory T cells (Fig. <ref type="figure" target="#fig_2">3I</ref>).</s><s>Notably, expanded T SCM reacquired CD45RA surface expression after 28 d of expansion, which further increased over time in frequency (Fig. <ref type="figure" target="#fig_2">3I, 3L</ref>) and in absolute numbers (Fig. <ref type="figure" target="#fig_2">3M</ref>).</s><s>At day 35, a substantial percentage of the CD45RA + T (TSCM) subset displayed CCR7 expression (Fig. <ref type="figure" target="#fig_2">3I, 3N</ref>).</s><s>The The Journal of Immunology CD45RA 2 T cells expanded from T SCM , however, were negative for CCR7 (data not shown).</s><s>Moreover, a considerable proportion of the expanded T SCM , but not of the expanded T MEM , expressed a T CM phenotype after 35 d of culture (Fig. <ref type="figure" target="#fig_2">3O</ref>).</s><s>We further aimed to show HCMV NLVP -multimer staining of CD8 + T (TSCM) and T (TMEM) to demonstrate the changes in the phenotypic markers over time in culture.</s><s>Likewise, a substantial percentage of the multimer + T (TSCM) subset displayed CCR7 expression at day 35, whereas multimer + T (MEM) were negative for CCR7 (Supplemental Fig. <ref type="figure" target="#fig_1">2A</ref>).</s><s>Interestingly, further cultivation of FACS-separated expanded CD45RA + CD45RO 2 and CD45RA 2 CD45RO + T (TSCM) on day 35 revealed a stable phenotypic differentiation pattern over the period of expansion up to 56 d after initial culture (Supplemental Fig. <ref type="figure" target="#fig_1">2B, 2C</ref>).</s></p><p><s>This selective ability of progeny from expanded T SCM to revert to CD45RA expression is intriguing.</s><s>Gattinoni and colleagues (8) noticed a low level of HNRPLL mRNA expression encoding heterogeneous nuclear ribonucleoprotein L-like, a key regulator of the alternative splicing of the CD45 pre-mRNA required for efficient CD45RO expression in T SCM <ref type="bibr" target="#b25">(22)</ref>.</s><s>In this regard, we compared the mRNA expression of this gene and related differentially expressed genes of T (TSCM) and T (TMEM) <ref type="bibr" target="#b11">(8)</ref>.</s><s>To this end, we performed quantitative real-time PCR to delineate naiveassociated gene expression and effector-associated gene expres- by guest on May 17, 2022 http://www.jimmunol.org/</s><s>Downloaded from sion in T (TSCM) and T (TMEM) at distinct time points after initial stimulation.</s><s>As expected, T (TSCM) expressed lower transcript levels of HNRPLL compared with T (TMEM) in the course of expansion (Fig. <ref type="figure" target="#fig_3">4A</ref>).</s><s>We further evaluated CD45RA gene expression by analyzing PTPRC.</s><s>To this end, we used an assay spanning exons 3 and 4, whereas the latter encodes for section A and is being removed in all other CD45 splice variants and therefore is specific for the CD45 isoform RA <ref type="bibr" target="#b26">(23)</ref>.</s><s>Strikingly, beginning at day 28, CD45RA (PTPRC) mRNA expression was increased in T (TSCM) , but not in T (TMEM) (Fig. <ref type="figure" target="#fig_3">4B</ref>).</s><s>In line with the capacity of T SCM to self-renew, KLRG1 as a marker of T cell senescence <ref type="bibr" target="#b27">(24)</ref> was decreased in T (TSCM) compared with T (TMEM) (Fig. <ref type="figure" target="#fig_3">4C</ref>).</s><s>Conversely, the expression of transcription factors that inhibit T cell activation and differentiation such as ceramide synthase 6, which promotes cellular quiescence by regulating intracellular ceramide levels <ref type="bibr" target="#b28">(25)</ref>, was elevated in T (TMEM) (Fig. <ref type="figure" target="#fig_3">4D</ref>).</s><s>mRNA expression of the effector-associated genes encoding for cytotoxic molecules like Perforin 1 and Granzyme A was similar in T (TSCM) and T (TMEM) until day 35 after expansion; however, it increased in T (TMEM) on day 42, indicating their terminal differentiation (Fig. <ref type="figure" target="#fig_3">4E, 4F</ref>).</s><s>Actinin a 1 and Lymphoid Enhancer-binding Factor 1 as naiveassociated genes <ref type="bibr" target="#b11">(8,</ref><ref type="bibr" target="#b29">26)</ref> were not differentially expressed in either probes in the course of expansion (data not shown).</s></p><p><s>The expression of the IL-7Ra (CD127) on Ag-specific T cells is associated with T cell engraftment after in vivo adoptive transfer experiments, and therefore is a marker for T cell fitness and persistence <ref type="bibr" target="#b30">(27)</ref>.</s><s>To further define the phenotype of expanded T MEM and T SCM , we assessed CD127 expression of both subsets after culturing (Fig. <ref type="figure" target="#fig_3">4G-I</ref>).</s><s>Intriguingly, expanded T SCM exhibited profound CD127 expression compared with T MEM (Fig. <ref type="figure" target="#fig_3">4G, 4H</ref>).</s><s>Further dissection of expanded CD45RA + and CD45RO + T SCM revealed higher CD127 expression on the former subset (Fig. <ref type="figure" target="#fig_3">4I</ref>).</s></p><p><s>Importantly, weekly antigenic restimulation resulted in T SCM , but not in T MEM , in a continuous expansion of .10</s><s>wk without signs of culture contraction.</s><s>Furthermore, the resting period was indispensable for the expanded T SCM to reacquire their initial phenotype (data not shown).</s></p><p><s>Altogether, the data suggest that a significant part of expanded viralspecific T SCM , in contrast with conventional defined viral-specific memory T cells, keep a cell-surface marker profile, which is similar to the phenotype ex vivo, indicating a potent self-renewal potential on antigenic stimuli.</s><s>Moreover, it appears that Ag-expanded T SCM become able to differentiate into all T cell lineages in vitro.</s></p><p><s>Functional viral-specific T SCM can be expanded from CD95 + T N Phenotypically, T SCM are assigned to the T N compartment.</s><s>To facilitate ex vivo expansion of HCMV-specific T SCM for transla-tion to clinical protocols, we aimed to expand these cells from a mixed T N compartment.</s><s>Moreover, we investigated whether CD95 expression on T N allows discrimination between Agspecific T SCM and Ag-inexperienced truly naive T cells.</s><s>Accordingly, we sort-purified CD45RA + CCR7 + and CD45RA + CCR7 + CD95 depleted T N by FACS to a purity .98%</s><s>(Fig. <ref type="figure">5A, 5B</ref>).</s><s>In parallel, T SCM were FACSorted from the same donors.</s><s>CD45RA + CCR7 + T N , CD45RA + CCR7 + CD95 depleted T N , and CD95 + T SCM were activated by an initial stimulation with autologous, lethally radiated HCMV pp65/IE1 peptide-pool pulsed CD3-depleted PBMCs and low doses of IL-7 and IL-15 (Fig. <ref type="figure">5A</ref>).</s><s>We then defined the expansion potential of the naive T cell-derived [T (TN) ], expanded naive CD95 depleted T cell-derived [T (TN-CD95-) ], and T (TSCM) populations.</s><s>All subsets were sensitive to the peptide-pool and cytokine-mediated stimuli, with enriched T SCM expanding more robustly than both T N populations (Fig. <ref type="figure">5C, 5D</ref>).</s><s>Expanded T N-CD95-showed a significantly reduced expansion potential compared with total T N (Fig. <ref type="figure">5C, 5D</ref>).</s><s>In line with the observed CD8 prevalence in Ag specifically expanded T SCM , these culture conditions predominantly induced proliferation of T N and T N-CD95-CD8 + T cells, but less CD4 + T cells (data not shown).</s><s>Intriguingly, depletion of CD95 from CD8 + T N before Ag-driven expansion abolished specific effector T cell cytokine formation (IFN-g and TNF-a) and upregulation of CD137 upon HCMV-specific activation (Fig. <ref type="figure">5E, 5F</ref>).</s><s>Owing to the higher overall fold expansion rate of T (TN) and T (TSCM) compared with T (TN-CD95-) (Fig. <ref type="figure">5C</ref>), absolute numbers were increased in HCMV-specific T (TN) and T (TSCM) (Fig. <ref type="figure">5G</ref>).</s><s>HCMV-specific T (TN) and T (TSCM) expansion was significantly higher compared with T (TN-CD95-) (Fig. <ref type="figure">5H</ref>).</s></p><p><s>Finally, we tested whether the culture conditions can induce naive T cell priming of HCMV-seronegative donors.</s><s>We activated CD45RA + CCR7 + naive T cells and PBMCs of an HCMV-seronegative donor with the same experimental approach.</s><s>Both naive T cells and PBMCs failed to induce cytokine production after HCMV-specific stimuli, excluding the possibility of naive T cell priming (Supplemental Fig. <ref type="figure" target="#fig_2">3</ref>).</s><s>Hence we reason that functional HCMV-specific T SCM can be expanded from the "mixed" T N compartment containing both naive and T SCM cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The presence and origin of long-lived memory T cells with stem cell-like abilities have been deliberated for some time <ref type="bibr" target="#b11">(8,</ref><ref type="bibr" target="#b31">28,</ref><ref type="bibr" target="#b32">29)</ref>.</s><s>In humans, T SCM have been recently identified <ref type="bibr" target="#b11">(8)</ref>.</s><s>Phenotypically, T SCM can be found within the T N compartment, where they were not identified for a long time.</s><s>T SCM are defined to exhibit the phenotypic profile CD45RO 2 CD45RA + CCR7 + CD62L + CD28 + CD127 + CD95 + and IL-2Rb + <ref type="bibr" target="#b11">(8)</ref>.</s><s>Another study deemed the characterization of T SCM to be adequate defined by the incremental gating of CD45RO 2 →CD45RA + →CD127 + →CCR7 + →CD95 + (15).</s><s>Their distinct functionality and unique homeostatic properties could be presented in a subsequent study in a nonhuman primate an-imal model during the course of an SIV infection <ref type="bibr" target="#b33">(30)</ref>.</s><s>Inter alia, those studies present HCMV-tetramer binding T SCM lymphocytes; however, functional data of HCMV-specific T SCM are missing <ref type="bibr" target="#b11">(8,</ref><ref type="bibr" target="#b16">13)</ref>.</s><s>In this study, we could demonstrate that T cells  <ref type="bibr" target="#b11">(8,</ref><ref type="bibr" target="#b18">15)</ref> can acquire a memorylike effector T cell cytokine formation pattern after short-term viral antigenic stimuli.</s><s>Hanley and colleagues (31) could demonstrate that Ag-specific T cells targeting viral epitopes could be primed and expanded from cord blood T cells with a naive phenotype.</s><s>Notwithstanding T SCM being phenotypically T N , rapid effector functionality evidences that T SCM are truly Agexperienced memory T cells <ref type="bibr" target="#b35">(32)</ref>.</s><s>Notably, T SCM lymphocytes of HCMV-seronegative donors with also no detectable memory T cells specific to HCMV epitopes failed to secrete effector cytokines in response to HCMV-antigenic stimuli.</s><s>Importantly, Gattinoni and colleagues <ref type="bibr" target="#b11">(8,</ref><ref type="bibr" target="#b29">26)</ref> generated T SCM from T N in the presence of the glycogen synthase kinase-3b inhibiting the Wnt-b-catenin pathway.</s><s>However, we aimed to isolate T SCM naturally generated in vivo according to their specific surface marker profile and expand viral Ag-specific T cells from this population without further addition of GSK-3b inhibitor because we do not intend to generate T SCM from T N , but rather expand ex vivo native T SCM in an Ag-specific manner.</s></p><p><s>We could detect Ag-specific T SCM lymphocytes in the peripheral blood of healthy humans that permits access to T SCM lymphocytes specific for viral Ags for analysis and adoptive transfer.</s><s>We successfully generated functional virus-specific CD8 + T cell lines from FACSort enriched T SCM lymphocytes.</s><s>Expanded T SCM lines were characterized by their differentiation capacity into distinct memory/effector T cell subsets, robust effector functions, high expansion potency, and self-renewal abilities in vitro.</s><s>Importantly, we have found a high TCR repertoire overlap between HCMVexpanded T (TMEM) and T (TSCM) , implying their closed relationship at the clonal level.</s></p><p><s>Remarkably, CD4 + T SCM cell expansion and cytokine production after specific stimuli were essentially absent.</s><s>Hence the phenotypic marker profile of CD4 + T SCM may not be defined yet.</s></p><p><s>Expanded T SCM show divergent surface marker expression of T cell differentiation over the duration of expansion, characterized by high expression of CD45RA, CCR7, CD127, and CD95 at culture initiation, followed by the acquisition of CD45RO accompanied by the loss of CD45RA, CCR7, and CD127 with proliferation.</s><s>Intriguingly, a substantial amount of expanded T SCM reacquired CD45RA, CCR7, and CD127 surface expression after 4 wk of expansion, implying self-renewal potency <ref type="bibr" target="#b36">(33)</ref>.</s><s>Importantly, expanded virus-specific T MEM failed to upregulate CD45RA, CCR7, and CD127 after expansion.</s><s>We assessed the status of CD45RO (HNRPLL) mRNA expression and related differentially expressed genes in virus specifically expanded T SCM and T MEM .</s><s>Noticeably, T SCM upregulate CD45RA mRNA expression and failed to upregulate CD45RO mRNA expression in the course of expansion, indicating cell-intrinsic transcriptional programs of self-renewal.</s><s>Furthermore, the expression of transcription factors that inhibit T cell activation and differentiation such as ceramide synthase 6 and a decreased mRNA expression of KLRG1 as a marker of T cell senescence indicate that T SCM should be considered a phenotypic and functional distinct population.</s><s>Conferring Cieri and colleagues <ref type="bibr" target="#b16">(13)</ref>, in the first 2 wk of expansion, we could detect CD45RA/CD45RO double positivity on T SCM , however, not on T MEM .</s><s>This unique feature of T SCM being able to express both CD45 splice variant needs further elucidation and cannot be answered by our studies.</s></p><p><s>Evidently, T MEM have a selective advantage over T SCM competing for instructive factors that is guiding their formation and expansion in vitro.</s><s>Furthermore, the early reacquisition of CD127 expression of T SCM after antigenic stimuli may give selective advantage for susceptibility to IL-7 to promote T SCM outgrowth.</s><s>Although IL-7 is not limited in our system, specific proliferation of T SCM from the bulk T cell pool with the addition of IL-7 could not be observed in this study.</s><s>This observation is in agreement with Cieri et al. <ref type="bibr" target="#b16">(13)</ref> reporting that the depletion of CD45RO + memory T cells or the isolation of naive T cells before initial stimulation is indispensable for the enrichment of T SCM -like lymphocytes in vitro.</s><s>The IL-7/CD127 interplay appears to be a critical determinant for T SCM generation and maintenance from T N <ref type="bibr" target="#b37">(34)</ref>.</s><s>However, the detailed cytokine requirements for Ag-specific T SCM expansion have yet to be elucidated.</s></p><p><s>Our culture conditions induced expanded virus-specific T SCM that become all T cell lineages at different time points of expansion.</s><s>Interestingly, we observed a divergent T cell differentiation pattern of expanded T SCM separated into CD45RA + CD45RO 2 and CD45RA 2 CD45RO + T cells after 5 wk of expansion.</s><s>The reacquisition after loss of CD45RA in CD45RA + CD45RO 2 T (TSCM) resulted in further contraction and expression of CCR7 to finally reacquire the phenotype of T SCM ex vivo, whereas T cells derived from CD45RA 2 CD45RO + T (TSCM) retained their phenotype.</s><s>This observation supports the model of an asymmetric division to a diverse T cell population in agreement with other reports <ref type="bibr" target="#b32">(29,</ref><ref type="bibr" target="#b38">35)</ref>.</s></p><p><s>We showed that virus-specific T SCM can be obtained by the enrichment and expansion of FACSorted T SCM .</s><s>For an effective translation into clinical trials, the procedure of Ag-specific T SCM enrichment and expansion has to be easy and good manufacturing practice compliant.</s><s>We could demonstrate the expansion of functional virus-specific CD8 + T cell lines from the T N -like compartment, which make the process more feasible and revealed higher yield.</s><s>Intriguingly, the depletion of CD95 + cells from T N compartment obliterated the expansion of viral-specific T cells, giving strong evidence that the resulting T cell population is indeed derived from the T SCM compartment <ref type="bibr" target="#b11">(8,</ref><ref type="bibr" target="#b16">13)</ref>.</s><s>Furthermore, this approach appears good manufacturing practice feasible using current state-of-the-art techniques because naive T cells comprising T SCM can be enriched by clinical-grade untouched magnetic separation <ref type="bibr" target="#b16">(13,</ref><ref type="bibr" target="#b40">36)</ref>.</s><s>Moreover, the growth factors IL-7 and IL-15 that we apply in our protocol for antiviral T SCM expansion that are certainly decisive for their expansion are being used in approved clinical protocols <ref type="bibr" target="#b14">(11,</ref><ref type="bibr" target="#b41">37,</ref><ref type="bibr" target="#b42">38)</ref>.</s><s>Besides, CD3-depleted PBMCs as APCs were sufficient for the expansion of T SCM , indicating that the Ag presentation requirements are fulfilled and that an enrichment or the generation of professional APCs like dendritic cells is not necessary per se.</s></p><p><s>Novel cancer-eradicating therapeutic approaches have been developed in the recent years <ref type="bibr" target="#b43">(39)</ref><ref type="bibr" target="#b44">(40)</ref><ref type="bibr" target="#b45">(41)</ref>.</s><s>T cells genetically modified by the incorporation of engineered receptors directed against cancer Ags have emerged to be a significant tool to combat cancer in first clinical trials <ref type="bibr" target="#b45">(41,</ref><ref type="bibr" target="#b46">42)</ref>.</s><s>The use of viral-specific T SCM or T N comprising T SCM might be particularly attractive to be applied in adoptive immunotherapeutic approaches to cancer patients by incorporating chimeric Ag receptors (CARs) to direct T SCM against defined tumor Ags <ref type="bibr" target="#b45">(41,</ref><ref type="bibr" target="#b47">43)</ref>.</s><s>Virus-specific T CM have been selectively transduced with a CAR directed against the CD19 Ag to facilitate their use in clinical trials to examine their superiority compared with other T cell subsets <ref type="bibr" target="#b48">(44)</ref>.</s><s>T SCM or T N comprising T SCM appear to be promising candidates to be tested in similar clinical protocols to define their therapeutic potential in clinical trials targeting cancer.</s><s>Specifically, viral-specific T SCM or T N comprising T SCM enriched to oligoclonality combined with the genetic incorporation of a CAR may be superior to currently used protocols to be better suited to function in the tumor environment by coupling anticancer efficacy with T cell persistence by inducing response to latent viral infections, which may be boosted by vaccination <ref type="bibr" target="#b16">(13)</ref>.</s><s>To this end, our findings enable direct access to human Ag-specific T SCM from PBLs targeting viral Ags and pave the way for rapid broad clinical application.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIGURE 1 .</head><label>1</label><figDesc><div><p><s>FIGURE 1. Viral-specific CD95 + human T SCM can be identified after short-term ex vivo stimulation.</s><s>(A) PBMCs were stimulated for 12 h with HCMV pp65/IE1 overlapping peptide pool or DMSO.</s><s>Frequency of T cell subsets and memory T cell response were assessed by flow cytometry.</s><s>(B) Gating on single alive CD3 + T lymphocytes and dissection into CD4 + and CD8 + T cells.</s><s>[(C and D) left column; summarized in (F) and (I)] Frequency of T cell subsets with representative FACS plots of CD45RA and CCR7 expression (T N , T EM , T EMRA , and T CM ).</s><s>[(C and D) right column; summarized in (G) and (J)] Memory T cell response of CD4 + (C) and CD8 + (D) T cells after 12-h HCMV pp65/IE1 peptide-pool stimulation segregated into T EMRA , T CM , T EM and T N according to CCR7 and CD45RA expression.</s><s>Cells were fixed, permeabilized, and stained for IFN-g and TNF-a.</s><s>[(E) summarized in (F), (G), (I), and (J)] Representative FACS plots of the phenotypic identification of T SCM according to CD45RA + , CCR7 + , CD127 + , and CD95 + expression (upper row: CD4 + ; lower row: CD8 + T cells) and IFN-g and TNF-a cytokine formation upon HCMV-specific stimuli.</s><s>(H and K) Absolute number of CD8 + T SCM responding to HCMV-stimuli correlates with that of the responding T cells within the CD8 + T N compartment, normalized to 1 3 10 6 CD8 + T cells (parametric Pearson correlation coefficient R 2 = 0.6165).</s><s>Mean data from at least eight healthy donors are presented.</s><s>(L) Flow-cytometric analysis of PBMCs from a representative healthy donor.</s><s>Overlaid histogram plots show expression levels of a given molecule in different CD4 + /CD8 + T cell subsets.</s><s>CD4 + /CD8 + T cell subsets were segregated into T SCM , T EMRA , T N , T CM , and T EM as defined in (D).</s></p></div></figDesc><graphic coords="5,47.57,82.05,466.34,398.90" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIGURE 2 .</head><label>2</label><figDesc><div><p><s>FIGURE 2. Isolation of human T SCM by polychromatic FACS.</s><s>(A) Schematic overview of the strategy for FACSort-purification of T MEM and T SCM .</s><s>Before FACSorting, CD3 + T cells have been pre-enriched from PBMCs by untouched MACS separation.</s><s>(B, upper row) FACSort of the T SCM population according to CD3 + , CD45RA + , CCR7 + , and CD95 + .</s><s>(B, lower row) FACS-purified T SCM population.</s><s>T SCM have been isolated to .98% purity.</s><s>(C) Left y-axis shows frequency of T SCM of CD3 + T N and total CD3 + T cells.</s><s>Right y-axis shows resulting absolute T SCM number of 3 3 10 7 CD3 + T cells after FACSorting.</s><s>Mean data from eight healthy donors are presented.</s></p></div></figDesc><graphic coords="6,112.49,74.01,105.45,91.82" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIGURE 3 .</head><label>3</label><figDesc><div><p><s>FIGURE 3. Viral-specific T SCM proliferate, show effector T cell functionality, differentiate, and self-renew on antigenic stimuli.</s><s>(A) Diagram summarizing the strategy to enrich and clonally expand HCMV-specific T SCM and HCMV-specific T MEM .</s><s>FACSorted T MEM (CD3 + ) and T SCM (CD3 + CD45RA + CCR7 + CD95 + ) were activated with HCMV pp65/IE1 peptide-pool pulsed and irradiated CD3-depleted autologous PBMCs in the ratio 1:10 and cultured with IL-7 (10 ng/ml) and IL-15 (10 ng/ml), followed by restimulation at day 7 with freshly isolated HCMV pp65/IE1 peptide-pool pulsed and irradiated CD3depleted autologous PBMCs in the ratio 1:10.</s><s>(B) T cell expansion (measured as fold increase) analyzed for each cell subset.</s><s>(C) Absolute numbers of T MEM -derived [T (TMEM) ] or T (TSCM) CD8 + T cells generated from purified T MEM or T SCM at different time point after initial stimulation.</s><s>(D) Quantification of CD8 + T cells at different time points after initial stimulation in each subset.</s><s>[(E) summarized in (F)] Expanded T TMEM (upper panel) and T TSCM (lower panel) show HCMV-specific effector T cell functionality at different time points (days 14-35) after initial culture defined by IFN-g and TNF-a cytokine formation and (G) Granzyme B expression (day 21) after HCMV-specific stimuli.</s><s>Cells were stimulated for 12 h with HCMV pp65/IE1 peptide-pool pulsed LCL in ratio 10:1.</s><s>IFN-g and TNF-a cytokine formation and Granzyme B expression were determined by intracellular staining.</s><s>Cells were permeabilized and stained for IFN-g, TNF-a, Granzyme B, CD3, CD4, and CD8.</s><s>Dot plot overlays: black dot population depicts unstimulated (DMSO-treated) cells; gray dot population depicts specifically stimulated cells.</s><s>Representative FACS plots are shown.</s><s>(H) HCMV-specific T cell expansion (measured as fold increase) analyzed for each cell subset.</s><s>[(I) frequency summarized in (L), absolute numbers in (M)] Representative FACS plots of CD45RA, CD45RO, and CCR7 expression on T (TMEM) and T (TSCM) CD8 + T cells (right panel shows CCR7 expression on day 35).</s><s>(J) Absolute numbers of HCMV-specific T (TMEM) or T (TSCM) CD8 + T cells.</s><s>(K) T (TMEM) and T (TSCM) show high TCR repertoire similarity within each donor.</s><s>Genomic DNA was extracted from T (TMEM) and T (TSCM) on day 14 after initial HCMV-specific stimulation.</s><s>Next generation sequencing was performed for TCR repertoire analysis.</s><s>Heat map indicates similarity of sample profiles.</s><s>The similarity considers the overlap between unique nucleotide sequences and within any two samples.</s><s>Three donors (D1-D3) have been analyzed.</s><s>(N and O) Quantification of CD45RA + CCR7 + double-positive (N) and CD45RA 2 CCR7 + T CM (O) cells at different time point after initial activation in each subset.</s><s>Mean data from six healthy donors are presented; error bars represent SEM.</s><s>*p , 0.05.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIGURE 4 .</head><label>4</label><figDesc><div><p><s>FIGURE 4. Viral-specific (TSCM) have a distinct mRNA expression and re-express IL-7Ra (CD127) after expansion.</s><s>(A-F) Expression of CD45RO (HNRPLL) (A), CD45RA (PTPRC) (B), KLRG1 (C), ceramide synthase 6 (D), Perforin 1 (E), and Granzyme A (F) in in vitroexpanded T (TSCM) and T (TMEM) were analyzed by quantitative PCR at time points days 14-42 after initial stimulation.</s><s>Data are given relative to hHPRT expression and are presented as box plots with mean and interquartile range of three donors.</s><s>(G) Representative FACS plots of CD127 expression on T (TMEM) and T (TSCM) CD8 + T cells at day 28 after initial stimulation.</s><s>(H) Quantification of CD8 + CD127 + double-positive cells at days 14 and 28 after initial stimulation in each subset.</s><s>(I) Representative FACS plots of CD127 expression gated on CD45RA + T (TSCM) and CD45RO + T (TSCM) .</s><s>Mean data from four healthy donors are presented; error bars represent SEM.</s><s>*p , 0.05.</s></p></div></figDesc><graphic coords="8,55.01,284.13,104.78,107.18" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc><div><p><s>by guest on May 17, 2022 http://www.jimmunol.org/</s><s>Downloaded from</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>GraphPad Prism version 6 was used for graphs and bar charts.</s><s>To test for normal Gaussian distribution, we performed Kolmogorov-Smirnov test.</s><s>Normally distributed data were evaluated using the Student t test.</s><s>If data were normally distributed, Student paired t test was used for analysis.</s><s>All t tests were two-tailed unless otherwise stated.</s><s>The p values #0.05 were</s></p></div></figDesc><table><row><cell>considered statistically significant, and significance is denoted as *p ,0.05.</cell></row><row><cell>Linear regression analysis was performed using GraphPad Prism; corre-</cell></row><row><cell>lations were assessed by Pearson and Spearman rank. T cell subset fold</cell></row><row><cell>expansion expresses T cell subset numbers (assessed by FACS) in re-</cell></row><row><cell>lation to total cell numbers of the indicated days post initial stimulation</cell></row><row><cell>and day 1.</cell></row><row><cell>Downloaded from</cell></row><row><cell>http://www.jimmunol.org/</cell></row><row><cell>by guest on May 17, 2022</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">by guest on May 17, 2022 http://www.jimmunol.org/ Downloaded from</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We thank Dr. Jason Millward (Institute of Medical Immunology, Charite Úniversity Medicine Berlin) for statistical advice.</s><s>We would like to acknowledge the assistance of the Berlin-Brandenburg Center for Regener-</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Dr. Chantip Dang-Heine for technical advice regarding preparations of DNA/RNA.</s><s>Disclosures M.S.-H., P.R., and H.-D.V. have a patent pending on the expansion protocol (Viral-antigen specific memory stem T cell preparations for adoptive immunotherapy, European patent application EP14196519.</s><s><ref type="bibr" target="#b7">4,</ref><ref type="bibr">2014)</ref>.</s><s>The other authors have no financial conflicts of interest.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">We thank Dr. B. Sawitzki (Institute of Medical Immunology, Charite ´University Medicine Berlin) for critical discussions and reading of the manuscript, M. Streitz (Institute of Medical Immunology, Charite Úniversity Medicine Berlin) for technical flow-cytometry assistance, and FIGURE 5. Functional viral-specific T SCM can be expanded from CD95 + T N . (A) Diagram summarizing the strategy to enrich and clonally expand HCMV-specific T SCM from the T N compartment</title>
		<author>
			<persName><forename type="first">.</forename><forename type="middle">D</forename><surname>Dr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kunkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dr</forename><forename type="middle">S</forename><surname>Maluck</surname></persName>
		</author>
		<author>
			<persName><surname>Meier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">FACSorted CD45RA + CCR7 + , CD45RA + CCR7 + CD95 depleted naive T cells, and T SCM were activated with HCMV pp65/IE1 peptide-pool pulsed and irradiated CD3-depleted autologous PBMCs in the ratio 1:10 and cultured with IL-7 (10 ng/ml) and IL-15 (10 ng/ml)</title>
				<imprint/>
		<respStmt>
			<orgName>ative Therapies Flow Cytometry Core Lab</orgName>
		</respStmt>
	</monogr>
	<note>followed by restimulation at day 7 with freshly isolated HCMV pp65/IE1 peptide-pool pulsed and irradiated CD3-depleted autologous PBMCs in the ratio 1:10</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Expanded T (TN) and T (TSCM) , but not T (TN-CD95-) , show HCMV-specific effector T cells functionality defined by IFN-g and TNF-a cytokine formation after HCMV-specific stimuli. Representative FACS plots are shown. Cells were stimulated for 12 h with HCMV pp65/IE1 peptide-pool pulsed LCL in ratio 10:1. IFN-g and TNF-a cytokine formation were determined by intracellular staining. Cells were permeabilized and stained for IFN-g, TNF-a, CD3, CD4, CD8, and CD137. Dot plot overlays: black dot population depicts unstimulated (DMSO-treated) cells</title>
		<author>
			<persName><forename type="first">N</forename><surname>Facsort Of The T N</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Scm Population According To Cd3 +</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cd45ra +</forename><surname>Ccr7</surname></persName>
		</author>
		<author>
			<persName><forename type="first">+</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Cd95</forename><forename type="middle">+</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ex</title>
		<imprint>
			<biblScope unit="page">D8</biblScope>
		</imprint>
	</monogr>
	<note>Upper panels show absence of CD45RO on each subset; lower panels show CD95/CCR7 expression pattern on each subset. (C) T cell expansion (measured as fold increase) analyzed for each cell subset. (D) Absolute numbers of T (TN) , CD95 depleted T N -derived [T (TN-CD95-) ], or T (TSCM) CD8 + T cells generated from purified T N , CD95 depleted T N , or T SCM at different time point after initial stimulation. gray dot population depicts specifically stimulated cells. (E, lower panel) Representative CD45RO expression on each subset. (G) Absolute numbers of HCMV-specific T (TN) , T (TSCM) , and T (TN-CD95-</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">H) HCMV-specific T cell expansion (measured as fold increase) analyzed for each cell subset. Mean data from six healthy donors are presented; error bars represent SEM</title>
		<author>
			<persName><surname>+ T Cells</surname></persName>
		</author>
		<imprint>
			<biblScope unit="page">5</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Walter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Gilbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Finch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Riddell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="page" from="1038" to="1044" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Rooney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Loftin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Sixbey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Srivastava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Bowman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Krance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Brenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Heslop</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="1549" to="1555" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">G</forename><surname>Brestrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zwinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schm€ Uck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ro ¨hmhild</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Hammer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kurtz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Uharek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Knosalla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lehmkuhl</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Adoptive T-cell therapy of a lung transplanted patient with severe CMV disease and resistance to antiviral therapy</title>
	</analytic>
	<monogr>
		<title level="j">Am. J. Transplant</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="1679" to="1684" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">CMV-specific T cell therapy</title>
		<author>
			<persName><forename type="first">H</forename><surname>Einsele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">U</forename><surname>Grigoleit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood Cells Mol. Dis</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="71" to="75" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)</title>
		<author>
			<persName><forename type="first">B</forename><surname>Savoldo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Goss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Hammer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Gee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">F</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Quiros-Tejeira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Reinke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schubert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="2942" to="2949" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">T-cell therapy in the treatment of post-transplant lymphoproliferative disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Bollard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Rooney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Heslop</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Clin. Oncol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="510" to="519" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Two subsets of memory T lymphocytes with distinct homing potentials and effector functions</title>
		<author>
			<persName><forename type="first">F</forename><surname>Sallusto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lenig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fo ¨rster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lipp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lanzavecchia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">401</biblScope>
			<biblScope unit="page" from="708" to="712" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">A human memory T cell subset with stem cell-like properties</title>
		<author>
			<persName><forename type="first">L</forename><surname>Gattinoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lugli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Pos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Paulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Quigley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Almeida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gostick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Carpenito</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1290" to="1297" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates</title>
		<author>
			<persName><forename type="first">C</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Lansdorp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Elliott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Riddell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="294" to="305" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice</title>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Forman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Riddell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Jensen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="1888" to="1898" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Preferential expansion of human virus-specific multifunctional central memory T cells by partial targeting of the IL-2 receptor signaling pathway: the key role of CD4+ T cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Schmueck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hammoud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Brestrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fuehrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-H</forename><surname>Luu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mueller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Babel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-D</forename><surname>Volk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Reinke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="page" from="5189" to="5198" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapy</title>
		<author>
			<persName><forename type="first">G</forename><surname>Brestrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zwinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Roemhild</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Noutsias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rohde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Keeren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sawitzki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-D</forename><surname>Volk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Reinke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Hammer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Immunother</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="932" to="940" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors</title>
		<author>
			<persName><forename type="first">N</forename><surname>Cieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Camisa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cocchiarella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Forcato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Oliveira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Provasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bondanza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bordignon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peccatori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ciceri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="573" to="584" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Transcriptional control of effector and memory CD8+ T cell differentiation</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Kaech</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Cui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Immunol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="749" to="761" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells</title>
		<author>
			<persName><forename type="first">E</forename><surname>Lugli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gattinoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Roberto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mavilio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Restifo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Roederer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Protoc</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="33" to="42" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Hammer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Brestrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Moosmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Kern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tesfa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Babel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mittenzweig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Rooney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hammerschmidt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur. J. Immunol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="2250" to="2258" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virusspecific T lymphocytes</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Heslop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Loftin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Krance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Brenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Rooney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="551" to="555" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Moosmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cobbold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zentz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-J</forename><surname>Delecluse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hollweck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Hislop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Blake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Croom-Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wollenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="1755" to="1764" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Comprehensive assessment of T-cell receptor b-chain diversity in alphabeta T cells</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Robins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">V</forename><surname>Campregher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Srivastava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Turtle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Kahsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Riddell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Warren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Carlson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="4099" to="4107" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Deep sequencing of the human TCRg and TCRb repertoires suggests that TCRb rearranges after ab and gd T cell commitment</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Sherwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Desmarais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Livingston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Andriesen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Haussler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Carlson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Robins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Transl. Med</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="90" to="61" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">IMGT/ JunctionAnalysis: The first tool for the analysis of the immunoglobulin and T cell receptor complex</title>
		<author>
			<persName><forename type="first">Yousfi</forename><surname>Monod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Giudicelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Chaume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Lefranc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">; V-J</forename></persName>
		</author>
		<author>
			<persName><forename type="first">V-D-J</forename><surname>Junctions</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioinformatics</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="379" to="385" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>Suppl. 1</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Regulation of CD45 alternative splicing by heterogeneous ribonucleoprotein, hnRNPLL</title>
		<author>
			<persName><forename type="first">S</forename><surname>Oberdoerffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Moita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Neems</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Freitas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hacohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">321</biblScope>
			<biblScope unit="page" from="686" to="691" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Human Langerhans cells express a novel form of the leukocyte common antigen (CD45)</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Szwejbka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schwandt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Invest. Dermatol</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="668" to="673" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Joshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chandele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Urso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hagman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gapin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Kaech</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="281" to="295" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Biologically active sphingolipids in cancer pathogenesis and treatment</title>
		<author>
			<persName><forename type="first">B</forename><surname>Ogretmen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">A</forename><surname>Hannun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Cancer</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="604" to="616" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells</title>
		<author>
			<persName><forename type="first">L</forename><surname>Gattinoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X.-S</forename><surname>Zhong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Palmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Hinrichs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wrzesinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Boni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cassard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Garvin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Med</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="808" to="813" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Kaech</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Wherry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Konieczny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Surh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ahmed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Immunol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="1191" to="1198" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Stem cell-like plasticity of naı ¨ve and distinct memory CD8+ T cell subsets</title>
		<author>
			<persName><forename type="first">C</forename><surname>Stemberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Neuenhahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Gebhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schiemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">R</forename><surname>Buchholz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Busch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin. Immunol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="62" to="68" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets</title>
		<author>
			<persName><forename type="first">C</forename><surname>Stemberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Huster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Koffler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Anderl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schiemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Busch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="985" to="997" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Superior T memory stem cell persistence supports long-lived T cell memory</title>
		<author>
			<persName><forename type="first">E</forename><surname>Lugli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Dominguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gattinoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Chattopadhyay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Bolton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Klatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Brenchley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vaccari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gostick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Invest</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="594" to="599" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Hanley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R Y</forename><surname>Cruz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Savoldo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Leen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stanojevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Khalil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Decker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Molldrem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Gee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="1958" to="1967" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Rapid effector function in CD8+ memory T cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lalvani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Brookes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hambleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Britton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Mcmichael</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="page" from="859" to="865" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Paths to stemness: building the ultimate antitumour T cell</title>
		<author>
			<persName><forename type="first">L</forename><surname>Gattinoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Klebanoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Restifo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Cancer</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="671" to="684" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Interleukin-7 receptor expression: intelligent design</title>
		<author>
			<persName><forename type="first">R</forename><surname>Mazzucchelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Durum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Immunol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="144" to="154" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">R</forename><surname>Palanivel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kinjyo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schambach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Intlekofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Banerjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Longworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Vinup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mrass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Oliaro</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Asymmetric T lymphocyte division in the initiation of adaptive immune responses</title>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">315</biblScope>
			<biblScope unit="page" from="1687" to="1691" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Moving T memory stem cells to the clinic</title>
		<author>
			<persName><forename type="first">L</forename><surname>Gattinoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Restifo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="567" to="568" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Heslop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Slobod</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Pule</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Hale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rousseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Bollard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Rochester</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="925" to="935" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections</title>
		<author>
			<persName><forename type="first">U</forename><surname>Gerdemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Keirnan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">L</forename><surname>Katari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Yanagisawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Christin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Huye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Perna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ennamuri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gottschalk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Brenner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Ther</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1622" to="1632" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Inducible apoptosis as a safety switch for adoptive cell therapy</title>
		<author>
			<persName><forename type="first">Di</forename><surname>Stasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>S.-K. Tey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fujita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kennedy-Nasser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Straathof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Durett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Grilley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N. Engl. J. Med</title>
		<imprint>
			<biblScope unit="volume">365</biblScope>
			<biblScope unit="page" from="1673" to="1683" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Engineered T cells for cancer treatment</title>
		<author>
			<persName><forename type="first">U</forename><surname>Anurathapan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Leen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Brenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Vera</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cytotherapy</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="713" to="733" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Design and development of therapies using chimeric antigen receptor-expressing T cells</title>
		<author>
			<persName><forename type="first">G</forename><surname>Dotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gottschalk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Savoldo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Brenner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol. Rev</title>
		<imprint>
			<biblScope unit="volume">257</biblScope>
			<biblScope unit="page" from="107" to="126" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Antibody-modified T cells: CARs take the front seat for hematologic malignancies</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Maus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Grupp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Porter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="2625" to="2635" />
			<date type="published" when="2014-06">June. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Chimeric antigen receptors (CARs) from benchto-bedside</title>
		<author>
			<persName><forename type="first">B</forename><surname>Savoldo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dotti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol. Lett</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="page" from="40" to="42" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Terakura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">N</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Gardner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Turtle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Riddell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="72" to="82" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">The Journal of Immunology</title>
		<imprint/>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
